AVNT - Avient Corporation
NYSE
->
Basic Materials
->
Specialty Chemicals
Avon Lake,
United States
Type: Equity
AVNT price evolution
AVNT
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $545.8 | $439.6 | $528.7 | $582.7 |
| Short term investments | ||||
| Net receivables | $399.9 | $436.9 | $506.4 | $484.4 |
| Inventory | $347 | $349.6 | $359 | $371.9 |
| Total current assets | $1407.6 | $1364.3 | $1510.7 | $1564.3 |
| Long term investments | ||||
| Property, plant & equipment | $1094.2 | $978.2 | $1007.4 | $1045.7 |
| Goodwill & intangible assets | $3310.1 | $3244.3 | $3320.4 | $3291.4 |
| Total noncurrent assets | $4560.9 | $4425.4 | $4541.1 | $4546.9 |
| Total investments | ||||
| Total assets | $5968.5 | $5789.7 | $6051.8 | $6111.2 |
| Current liabilities | ||||
| Accounts payable | $432.3 | $389.5 | $428.7 | $448.1 |
| Deferred revenue | ||||
| Short long term debt | $26.1 | $9.5 | $2.2 | $2.2 |
| Total current liabilities | $773.6 | $727.1 | $776.5 | $837.2 |
| Long term debt | $2113.7 | $2070.8 | $2179.2 | $2177.7 |
| Total noncurrent liabilities | $2856.9 | $2766.7 | $2921.6 | $2905.4 |
| Total debt | $2139.8 | $2080.3 | $2181.4 | $2179.9 |
| Total liabilities | $3630.5 | $3493.8 | $3698.1 | $3742.6 |
| Shareholders' equity | ||||
| Retained earnings | $1808.2 | $1803.1 | $1820.5 | $1820.9 |
| Other shareholder equity | -$87.4 | -$121.1 | -$77.6 | -$59.7 |
| Total shareholder equity | $2319.2 | $2276.9 | $2334.7 | $2349.8 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $545.8 | $641.1 | $601.2 | $649.5 |
| Short term investments | ||||
| Net receivables | $399.9 | $440.6 | $642.3 | $516.6 |
| Inventory | $347 | $372.7 | $461.1 | $327.5 |
| Total current assets | $1407.6 | $1569.7 | $1827 | $1602.1 |
| Long term investments | ||||
| Property, plant & equipment | $1094.2 | $1109.6 | $750.2 | $775.8 |
| Goodwill & intangible assets | $3310.1 | $3269.5 | $2211.6 | $2316.6 |
| Total noncurrent assets | $4560.9 | $4515.3 | $3170.2 | $3268.4 |
| Total investments | ||||
| Total assets | $5968.5 | $6085 | $4997.2 | $4870.5 |
| Current liabilities | ||||
| Accounts payable | $432.3 | $454.4 | $553.9 | $471.7 |
| Deferred revenue | ||||
| Short long term debt | $26.1 | $19.2 | $32.8 | $43.7 |
| Total current liabilities | $773.6 | $869.4 | $940.6 | $801 |
| Long term debt | $2113.7 | $2176.7 | $1900.4 | $1910 |
| Total noncurrent liabilities | $2856.9 | $2862.8 | $2266.1 | $2357.8 |
| Total debt | $2139.8 | $2236.8 | $1933.2 | $1953.7 |
| Total liabilities | $3630.5 | $3750.5 | $3206.7 | $3158.8 |
| Shareholders' equity | ||||
| Retained earnings | $1808.2 | $1823.6 | $1208 | $1057.4 |
| Other shareholder equity | -$87.4 | $11.5 | -$45.6 | $26.4 |
| Total shareholder equity | $2319.2 | $2334.5 | $1774.7 | $1697.1 |
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $753.7 | $824.4 | $845.7 | |
| Cost of revenue | $558.4 | $583.7 | $598.1 | |
| Gross Profit | $195.3 | $240.7 | $247.6 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $161 | $178.4 | $190.5 | |
| Total operating expenses | $161 | $178.4 | $190.5 | |
| Operating income | $34.3 | $62.3 | $57.1 | |
| Income from continuing operations | ||||
| EBIT | $35.3 | $61.9 | $56.4 | |
| Income tax expense | -$0.1 | $10.4 | $7.7 | |
| Interest expense | $30.3 | $29.4 | $28.8 | |
| Net income | ||||
| Net income | $5.1 | $22.1 | $19.9 | |
| Income (for common shares) | $5.1 | $22.1 | $19.9 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3142.8 | $3396.9 | $3242.1 | |
| Cost of revenue | $2250.3 | $2514.2 | $2457.8 | |
| Gross Profit | $892.5 | $882.7 | $784.3 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $695.7 | $639.4 | $595 | |
| Total operating expenses | $695.7 | $639.4 | $595 | |
| Operating income | $196.8 | $243.3 | $189.3 | |
| Income from continuing operations | ||||
| EBIT | $202 | $803.6 | $211.4 | |
| Income tax expense | $11 | -$19.3 | $5.2 | |
| Interest expense | $115.3 | $119.8 | $74.6 | |
| Net income | ||||
| Net income | $75.7 | $703.1 | $131.6 | |
| Income (for common shares) | $75.7 | $703.1 | $131.6 | |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $28.6 | $5.1 | $22.1 | $19.9 |
| Operating activities | ||||
| Depreciation | $44.3 | $46.4 | $47.6 | $50.5 |
| Business acquisitions & disposals | $7.3 | |||
| Stock-based compensation | $3.5 | $3.2 | $3.3 | $3.2 |
| Total cash flows from operations | $154.5 | $71.8 | -$2.5 | -$22.2 |
| Investing activities | ||||
| Capital expenditures | -$36.8 | -$29.1 | -$25.6 | -$20.3 |
| Investments | ||||
| Total cash flows from investing | -$28.8 | -$26.8 | -$25.6 | -$13 |
| Financing activities | ||||
| Dividends paid | -$22.6 | -$22.6 | -$22.5 | -$22.5 |
| Sale and purchase of stock | ||||
| Net borrowings | -$2 | -$102.8 | -$0.2 | -$0.8 |
| Total cash flows from financing | -$25.7 | -$127.7 | -$22.7 | -$25.6 |
| Effect of exchange rate | $6.2 | -$6.4 | -$3.2 | $2.4 |
| Change in cash and equivalents | $106.2 | -$89.1 | -$54 | -$58.4 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $75.7 | $703.1 | $230.8 | $131.6 |
| Operating activities | ||||
| Depreciation | $188.8 | $163.1 | $145.9 | $111.8 |
| Business acquisitions & disposals | $7.3 | -$497.9 | -$47.6 | -$1373.1 |
| Stock-based compensation | $13.2 | $13.2 | $11.2 | $11.3 |
| Total cash flows from operations | $201.6 | $398.4 | $233.8 | $221.6 |
| Investing activities | ||||
| Capital expenditures | -$111.8 | -$105.5 | -$100.6 | -$63.7 |
| Investments | ||||
| Total cash flows from investing | -$94.2 | -$504 | -$150.2 | -$1431.6 |
| Financing activities | ||||
| Dividends paid | -$90.2 | -$86.8 | -$77.7 | -$71.3 |
| Sale and purchase of stock | -$36.4 | -$4.2 | $473.7 | |
| Net borrowings | -$105.8 | $343.2 | -$18.5 | $642.2 |
| Total cash flows from financing | -$201.7 | $166.4 | -$114.6 | $982 |
| Effect of exchange rate | -$1 | -$20.9 | -$17.3 | $12.8 |
| Change in cash and equivalents | -$95.3 | $39.9 | -$48.3 | -$215.2 |
News
Fundamentals
| Market cap | $3.90B |
|---|---|
| Enterprise value | $5.50B |
| Shares outstanding | 90.90M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 1.62 |
| Book/Share | 26.48 |
| Cash/Share | 6.00 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.57 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.82 |
| Quick ratio | 1.37 |